RBFOX3 and neoplasm: Ass1 is a key enzyme in arginine biosynthesis, and in patients with cancer, low Ass1 expression in tumor tissues is associated with poor prognosis.[28] We took O.E. Rbfox3 as the control group and O.E. Rbfox3 + O.E. Ass1 as the experimental group.